![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Lung Cancer |
Free Subscription
1 Am J Clin Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy
in the Treatment of Limited-Stage Small Cell Lung Cancer: A Matched-Pair
Analysis.
Am J Clin Oncol. 2023 Nov 20. doi: 10.1097/COC.0000000000001066.
PubMed
Abstract available
Standardized Classification of Lung Adenocarcinoma Subtypes and Improvement of
Grading Assessment Through Deep Learning.
Am J Pathol. 2023;193:2066-2079.
PubMed
Abstract available
Circulating tumor DNA and radiological tumor volume identify patients at risk for
relapse with resected, early-stage non-small cell lung cancer.
Ann Oncol. 2023 Nov 20:S0923-7534(23)05072-X. doi: 10.1016/j.annonc.2023.
PubMed
Abstract available
ASO Visual Abstract: Effect of Preoperative Home-Based Exercise Training on
Quality of Life After Lung Cancer Surgery: A Multicenter Randomized Controlled
Trial.
Ann Surg Oncol. 2023 Nov 17. doi: 10.1245/s10434-023-14602.
PubMed
ASO Author Reflections: Impact of a Preoperative Home-Based Exercise Program on
Quality of Life After Lung Cancer Resection.
Ann Surg Oncol. 2023 Nov 19. doi: 10.1245/s10434-023-14620.
PubMed
Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer
in the United States.
Ann Thorac Surg. 2023 Nov 21:S0003-4975(23)01165.
PubMed
Abstract available
Alveolar Macrophage Expression Differs According to Lung Cancer Subtype.
Arch Bronconeumol. 2023 Nov 9:S0300-2896(23)00363.
PubMed
Characterization of genomic instability-related genes predicts survival and
therapeutic response in lung adenocarcinoma.
BMC Cancer. 2023;23:1115.
PubMed
Abstract available
Lymphocyte migration regulation related proteins in urine exosomes may serve as a
potential biomarker for lung cancer diagnosis.
BMC Cancer. 2023;23:1125.
PubMed
Abstract available
Circulating tumour cells and PD-L1-positive small extracellular vesicles: the
liquid biopsy combination for prognostic information in patients with metastatic
non-small cell lung cancer.
Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02491.
PubMed
Abstract available
Metformin as a booster or obstacle of immunotherapy in patients with non-small
cell lung cancer and diabetes mellitus.
Cancer. 2023 Nov 21. doi: 10.1002/cncr.35111.
PubMed
Reply to "Metformin as a booster or obstacle of immunotherapy in patients with
non-small cell lung cancer and diabetes mellitus".
Cancer. 2023 Nov 21. doi: 10.1002/cncr.35134.
PubMed
Hypoxia-induced circ-CDYL-EEF1A2 transcriptional complex drives lung metastasis
of cancer stem cells from hepatocellular carcinoma.
Cancer Lett. 2023;578:216442.
PubMed
Abstract available
Associations between Sex-Specific Reproductive factors and Risk of New-Onset Lung
Cancer Among Women.
Chest. 2023 Nov 15:S0012-3692(23)05709-4. doi: 10.1016/j.chest.2023.
PubMed
Abstract available
The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic
Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to
the Chemo-Immunotherapy Era: A Single Institution Series.
Clin Lung Cancer. 2023;24:696-705.
PubMed
Abstract available
A Phase ? Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and
Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung
Cancer: TORG2241 (UBE-Q).
Clin Lung Cancer. 2023 Oct 4:S1525-7304(23)00186.
PubMed
Abstract available
Barriers to Timely Lung Cancer Care in Early Stage Non-Small Cell Lung Cancer and
Impact on Patient Outcomes.
Clin Lung Cancer. 2023 Oct 31:S1525-7304(23)00226.
PubMed
Abstract available
A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously
Treated Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2023 Oct 26:S1525-7304(23)00224.
PubMed
Abstract available
Machine-Learning-Aided Prediction of Brain Metastases Development in
Non-Small-Cell Lung Cancers.
Clin Lung Cancer. 2023;24:e311-e322.
PubMed
Abstract available
PET-CT SUV(max) and Endobronchial Ultrasound Features for Prediction of
Malignancy: A Prospective Study.
Clin Lung Cancer. 2023;24:753-760.
PubMed
Abstract available
An Effective Malignancy Prediction Model for Incidentally Detected Pulmonary
Subsolid Nodules Based on Current and Prior CT Scans.
Clin Lung Cancer. 2023;24:e301-e310.
PubMed
Abstract available
Small Cell Carcinoma of the Ureter With Early Recurrence and Multiple Metastases
Shown on 18F-FDG PET/CT.
Clin Nucl Med. 2023 Sep 7. doi: 10.1097/RLU.0000000000004828.
PubMed
Abstract available
Combining atezolizumab 1200 mg with bevacizumab 15 mg/kg: based on science or
just revenues?
Eur J Cancer. 2023;194:113349.
PubMed
Abstract available
Osimertinib-induced urticarial vasculitis in a patient with lung cancer: A rare
cutaneous toxicity.
Eur J Cancer. 2023;196:113432.
PubMed
Lack of Incremental Value of Three-Dimensional Measurement in Assessing
Invasiveness for Lung Cancer.
Eur J Cardiothorac Surg. 2023 Nov 17:ezad373. doi: 10.1093.
PubMed
Abstract available
Prevalence and anatomical characteristics of medial-basal segment in right lung.
Eur J Cardiothorac Surg. 2023;64:ezad342.
PubMed
Abstract available
Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral
Thoracic Tumors?
Int J Radiat Oncol Biol Phys. 2023;117:1232-1235.
PubMed
The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?
Int J Radiat Oncol Biol Phys. 2023;117:1047.
PubMed
MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified
Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08139.
PubMed
Abstract available
SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function,
Dyspnea, and Quality of Life.
Int J Radiat Oncol Biol Phys. 2023;117:1213-1221.
PubMed
Abstract available
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From
Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
Int J Radiat Oncol Biol Phys. 2023;117:1222-1231.
PubMed
Abstract available
Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on
Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology
RTOG 0617.
Int J Radiat Oncol Biol Phys. 2023;117:1270-1286.
PubMed
Abstract available
Comprehensive assessment of base excision repair (BER)-related lncRNAs as
prognostic and functional biomarkers in lung adenocarcinoma: implications for
personalized therapeutics and immunomodulation.
J Cancer Res Clin Oncol. 2023;149:17199-17213.
PubMed
Abstract available
Efficacy of rechallenge immunotherapy after immune monotherapy resistance in
patients with advanced non-small cell lung cancer.
J Cancer Res Clin Oncol. 2023 Nov 17. doi: 10.1007/s00432-023-05490.
PubMed
Abstract available
Selective Personalized Radioimmunotherapy for Locally Advanced Non-Small-Cell
Lung Cancer Trial.
J Clin Oncol. 2023 Nov 21:JCO2300627. doi: 10.1200/JCO.23.00627.
PubMed
Abstract available
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in
Untreated Extensive-Stage Small-Cell Lung Cancer.
J Clin Oncol. 2023 Nov 17:JCO2301363. doi: 10.1200/JCO.23.01363.
PubMed
Abstract available
Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation
Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes.
J Nucl Med. 2023 Nov 16:jnumed.123.266002. doi: 10.2967/jnumed.123.266002.
PubMed
Abstract available
Analyzing the Impact of the COVID-19 Pandemic on Initial Oncologic Presentation
and Treatment of Non-Small Cell Lung Cancer in the United States.
J Thorac Cardiovasc Surg. 2023 Nov 17:S0022-5223(23)01098.
PubMed
Abstract available
Preoperative Mediastinal Staging in Early-Stage Lung Cancer: Targeted Nodal
Sampling is Not Inferior to Systematic Nodal Sampling.
J Thorac Cardiovasc Surg. 2023 Nov 17:S0022-5223(23)01096.
PubMed
Abstract available
Discussion to: Association of socioeconomic factors with the receipt of
neoadjuvant therapy for patients with non-small cell lung cancer.
J Thorac Cardiovasc Surg. 2023 Nov 17:S0022-5223(23)00979.
PubMed
The International Association for the Study of Lung Cancer Thymic Epithelial
Tumor Staging Project: Proposal for the T Component for the Forthcoming (Ninth)
Edition of the TNM Classification of Malignant Tumors.
J Thorac Oncol. 2023;18:1638-1654.
PubMed
Abstract available
The International Association for the Study of Lung Cancer Thymic Epithelial
Tumor Staging Project: A Re-Assessment of the International Thymic Malignancy
Interest Group/International Association for the Study of Lung Cancer Lymph Node
Map for Thymic
J Thorac Oncol. 2023;18:1672-1688.
PubMed
Abstract available
The International Association for the Study of Lung Cancer Thymic Epithelial
Tumors Staging Project: Proposal for a Stage Classification for the Forthcoming
(Ninth) Edition of the TNM Classification of Malignant Tumors.
J Thorac Oncol. 2023;18:1655-1671.
PubMed
Abstract available
Lung Cancer in Albania.
J Thorac Oncol. 2023;18:1632-1637.
PubMed
Moving Toward Rationale Phase 3 Designs for Advanced NSCLC.
J Thorac Oncol. 2023;18:1629-1631.
PubMed
Third-Generation EGFR Tyrosine Kinase Inhibitor for Central Nervous System
Metastases EGFR-Mutant NSCLC: Current Evidence and Future Perspectives.
J Thorac Oncol. 2023;18:1625-1628.
PubMed
Genotype Versus Phenotype: Defining Predictive Biomarkers of Immunotherapy
Response.
J Thorac Oncol. 2023;18:1615-1617.
PubMed
Incidentally-Detected Lung Cancer in Persons Too Young or Too Old for Lung Cancer
Screening in a Mississippi Delta Cohort.
J Thorac Oncol. 2023 Nov 18:S1556-0864(23)02371.
PubMed
Abstract available
Allelic context of EGFR C797X mutant lung cancer defines four subtypes with
heterogeneous genomic landscape and distinct clinical outcomes.
J Thorac Oncol. 2023 Nov 17:S1556-0864(23)02372.
PubMed
Abstract available
Perspective on Management of LDCT Findings on Low-Dose Computed Tomography
Examinations for Lung Cancer Screening From the IASLC Early Detection & Screening
Committee.
J Thorac Oncol. 2023 Nov 16:S1556-0864(23)02369.
PubMed
Abstract available
Outcomes in Incidentally Versus Screening Detected Stage I Lung Cancer Surgery
Patients.
J Thorac Oncol. 2023 Nov 15:S1556-0864(23)02364.
PubMed
Abstract available
No Additional Effect of a Personalized Tobacco Treatment Intervention on Smoking
Abstinence in Individuals Eligible for Lung Cancer Screening: Brief Report of a
Randomized Trial.
J Thorac Oncol. 2023 Nov 15:S1556-0864(23)02368.
PubMed
Abstract available
Clinical Significance of the Proposed Pathologic Criteria for Invasion by the
International Association for the Study of Lung Cancer in Resected Nonmucinous
Lung Adenocarcinoma.
J Thorac Oncol. 2023 Nov 2:S1556-0864(23)02311.
PubMed
Abstract available
Osimertinib in Patients With Non-Small Cell Lung Cancer and Uncommon EGFR
Mutations-Chasing Unicorns?
JAMA Oncol. 2023 Nov 22. doi: 10.1001/jamaoncol.2023.5004.
PubMed
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With
Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial.
JAMA Oncol. 2023;9:1574-1582.
PubMed
Abstract available
Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR
Phase 2 Nonrandomized Controlled Trial.
JAMA Oncol. 2023;9:1525-1534.
PubMed
Abstract available
Eligibility for screening with low-dose CT in a real-world cohort of patients
with lung cancer in Greece: A brief report.
Lung Cancer. 2023;186:107424.
PubMed
Abstract available
Osimertinib as first-line treatment for elderly patients with advanced EGFR
mutation-positive non-small cell lung cancer in a real-world setting
(OSI-FACT-EP).
Lung Cancer. 2023;186:107426.
PubMed
Abstract available
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus
chemotherapy as first-line treatment for metastatic non-small-cell lung cancer
(POSEIDON).
Lung Cancer. 2023;186:107422.
PubMed
Abstract available
D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the
progression of NSCLC.
Oncogene. 2023;42:3503-3513.
PubMed
Abstract available
Novel breath biomarkers identification for early detection of hepatocellular
carcinoma and cirrhosis using ML tools and GCMS.
PLoS One. 2023;18:e0287465.
PubMed
Abstract available
Novel electromagnetic navigation bronchoscopy system for the diagnosis of
peripheral pulmonary nodules: a prospective, multicentre study.
Thorax. 2023;78:1197-1205.
PubMed
Abstract available
Thank you for your interest in scientific medicine.